MRDR-based FRAIL-M trial now has 10 sites & 10 patients recruited!
$5.3 million funding over 5 years approved for APAC MRDR
The MRDR has reached 4000 patients registered!
We invite you to the free MRDR webinar: 5 Sept, 4-5pm
Real-time feedback of patient-reported outcomes feasible for patients and clinicians!
MRDR still operating during COVID-19 pandemic.
The Myeloma 1000 Biobank now has samples from over 400 patients!
FRAIL-M, a trial using MRDR infrastructure, has commenced recruitment.
Dr Jessie Zhao's presentation on treatment patterns in myeloma was awarded a Snowdome travel grant.
The MRDR was well represented at the Blood 2019 conference in Perth in October.